NO20003964L - Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav - Google Patents

Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav

Info

Publication number
NO20003964L
NO20003964L NO20003964A NO20003964A NO20003964L NO 20003964 L NO20003964 L NO 20003964L NO 20003964 A NO20003964 A NO 20003964A NO 20003964 A NO20003964 A NO 20003964A NO 20003964 L NO20003964 L NO 20003964L
Authority
NO
Norway
Prior art keywords
receptors
models
applications
dimensional structures
dimensional
Prior art date
Application number
NO20003964A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003964D0 (no
Inventor
P Mark Hogarth
Maree S Powell
Ian F Mckenzie
Kelly F Maxwell
Thomas P J Garett
Vidana Epa
Jonathan B Baell
Barry R Matthews
Thomas D Mccarthy
Geoffrey A Pietersz
Original Assignee
Ilexus Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilexus Pty Ltd filed Critical Ilexus Pty Ltd
Publication of NO20003964D0 publication Critical patent/NO20003964D0/no
Publication of NO20003964L publication Critical patent/NO20003964L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Processing Or Creating Images (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20003964A 1998-02-06 2000-08-04 Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav NO20003964L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7397298P 1998-02-06 1998-02-06
US9999498P 1998-09-11 1998-09-11
PCT/IB1999/000367 WO1999040117A1 (fr) 1998-02-06 1999-02-04 STRUCTURES TRIDIMENSIONNELLES ET MODELES DE RECEPTEURS Fc, ET LEURS UTILISATIONS

Publications (2)

Publication Number Publication Date
NO20003964D0 NO20003964D0 (no) 2000-08-04
NO20003964L true NO20003964L (no) 2000-10-04

Family

ID=26755120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003964A NO20003964L (no) 1998-02-06 2000-08-04 Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav

Country Status (16)

Country Link
US (2) US6675105B2 (fr)
EP (1) EP1053255A4 (fr)
JP (1) JP2004510681A (fr)
KR (1) KR20010024899A (fr)
CN (1) CN1291198A (fr)
AP (1) AP2000001876A0 (fr)
AU (1) AU759378B2 (fr)
BR (1) BR9907964A (fr)
CA (1) CA2316860A1 (fr)
EA (1) EA200000746A1 (fr)
IL (1) IL137583A0 (fr)
NO (1) NO20003964L (fr)
NZ (1) NZ505914A (fr)
PL (1) PL342297A1 (fr)
TR (1) TR200002271T2 (fr)
WO (1) WO1999040117A1 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553809B2 (en) 1998-02-06 2009-06-30 Ilexus Pty Limited Fc receptor modulators and uses thereof
CN1189166C (zh) * 1998-09-11 2005-02-16 伊来克萨斯独资有限公司 Fc受体调节剂及其应用
AU770150B2 (en) * 1998-11-05 2004-02-12 Heska Corporation Three-dimensional model of a FC epsilon receptor alpha chain and uses thereof
EP1006183A1 (fr) * 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Récepteurs Fc recombinantes et solubles
US7912689B1 (en) 1999-02-11 2011-03-22 Cambridgesoft Corporation Enhancing structure diagram generation through use of symmetry
US7295931B1 (en) * 1999-02-18 2007-11-13 Cambridgesoft Corporation Deriving fixed bond information
US6850876B1 (en) * 1999-05-04 2005-02-01 Smithkline Beecham Corporation Cell based binning methods and cell coverage system for molecule selection
US6889145B1 (en) 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
US7356419B1 (en) 2000-05-05 2008-04-08 Cambridgesoft Corporation Deriving product information
US7272509B1 (en) * 2000-05-05 2007-09-18 Cambridgesoft Corporation Managing product information
IL144082A0 (en) * 2000-07-14 2002-05-23 Medical Res Council Crystal structure of antibiotics bound to the 30s ribosome and its use
GB0029871D0 (en) * 2000-07-14 2001-01-24 Medical Res Council Crystal structure (V)
EP1201681A1 (fr) * 2000-10-30 2002-05-02 Millennium Pharmaceuticals, Inc. Molécules "Fail" et leurs utilisations
CN1245215C (zh) 2001-02-28 2006-03-15 四川省生物工程研究中心 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
US20040219632A1 (en) * 2001-04-20 2004-11-04 Robert Margolskee T1r3 a novel taste receptor
ES2334494T5 (es) 2001-05-11 2013-05-29 Ludwig Institute For Cancer Research Ltd. Proteínas de unión específicas y usos de las mismas
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
DE10157290A1 (de) * 2001-11-22 2003-06-05 Max Planck Gesellschaft Pharmazeutische Zusammensetzung enthaltend sFcRgamma IIb oder sFcRgamma III
WO2003088125A2 (fr) * 2002-04-10 2003-10-23 Transtech Pharma, Inc. Systeme et procede d'integration d'une decouverte moleculaire assistee par ordinateur
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
JP2007525149A (ja) 2003-01-13 2007-09-06 マクロジェニクス，インコーポレーテッド 可溶性ＦｃγＲ融合タンパク質およびその使用法
NZ543430A (en) * 2003-05-26 2008-06-30 Biotie Therapies Corp Crystalline VAP-1 and uses thereof
US7585647B2 (en) 2003-08-28 2009-09-08 Guangwen Wei Nucleic acid encoding recombinant interferon
CA2555684A1 (fr) * 2004-02-10 2005-08-18 The Austin Research Institute Structures cristallines et modeles pour recepteurs fc et utilisations associees pour la conception et l'identification de composes modulateurs des recepteurs fc
WO2006133486A1 (fr) * 2005-06-14 2006-12-21 The Macfarlane Burnet Institute For Medical Research And Public Health Limited Structures cristallines et modeles de complexes fc/recepteurs fc et utilisations de ces derniers
AU2008218925A1 (en) * 2007-02-20 2008-08-28 Anaptysbio, Inc. Somatic hypermutation systems
WO2011140148A1 (fr) * 2010-05-03 2011-11-10 Cambridgesoft Corporation Systèmes, procédés et appareil de traitement de documents pour identifier des structures chimiques
TWI687439B (zh) 2011-06-30 2020-03-11 中外製藥股份有限公司 異源二聚化多胜肽
US9977876B2 (en) 2012-02-24 2018-05-22 Perkinelmer Informatics, Inc. Systems, methods, and apparatus for drawing chemical structures using touch and gestures
WO2013187495A1 (fr) 2012-06-14 2013-12-19 中外製薬株式会社 MOLÉCULE DE LIAISON À L'ANTIGÈNE CONTENANT UNE RÉGION Fc MODIFIÉE
NZ705370A (en) 2012-08-24 2018-06-29 Chugai Pharmaceutical Co Ltd Fcγriib-specific fc region variant
US9535583B2 (en) 2012-12-13 2017-01-03 Perkinelmer Informatics, Inc. Draw-ahead feature for chemical structure drawing applications
DK2940135T5 (da) * 2012-12-27 2021-09-20 Chugai Pharmaceutical Co Ltd Heterodimeriseret polypeptid
US8854361B1 (en) 2013-03-13 2014-10-07 Cambridgesoft Corporation Visually augmenting a graphical rendering of a chemical structure representation or biological sequence representation with multi-dimensional information
AU2014250074B2 (en) 2013-03-13 2019-04-04 Perkinelmer Informatics, Inc. Systems and methods for gesture-based sharing of data between separate electronic devices
CA2908350C (fr) 2013-04-02 2023-08-08 Futa Mimoto Variant de region fc
US9430127B2 (en) 2013-05-08 2016-08-30 Cambridgesoft Corporation Systems and methods for providing feedback cues for touch screen interface interaction with chemical and biological structure drawing applications
US9751294B2 (en) 2013-05-09 2017-09-05 Perkinelmer Informatics, Inc. Systems and methods for translating three dimensional graphic molecular models to computer aided design format
JP7127859B2 (ja) 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
US10572545B2 (en) 2017-03-03 2020-02-25 Perkinelmer Informatics, Inc Systems and methods for searching and indexing documents comprising chemical information
KR101987292B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2B45.1
KR101987279B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A45.1
KR101987268B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A45
AU2018332475B2 (en) * 2017-09-15 2020-12-17 Kookmin University Industry Academy Cooperation Foundation Fc-gamma receptor mutants
KR101986252B1 (ko) * 2017-09-15 2019-06-05 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A28
KR101986250B1 (ko) * 2017-09-15 2019-06-05 국민대학교 산학협력단 Fc 감마 수용체 변이체 SH2A40
KR101987272B1 (ko) * 2017-09-15 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A28.1
US12060437B2 (en) 2018-03-23 2024-08-13 North Carolina State University Methods and compositions for antibody to high affinity receptor for IgE
CN115035947B (zh) * 2022-06-10 2023-03-10 水木未来(北京)科技有限公司 蛋白质结构建模方法及装置、电子设备和存储介质

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858981A (en) * 1993-09-30 1999-01-12 University Of Pennsylvania Method of inhibiting phagocytosis
CN1189166C (zh) * 1998-09-11 2005-02-16 伊来克萨斯独资有限公司 Fc受体调节剂及其应用
AU2001278771A1 (en) * 2000-08-22 2002-03-04 Ono Pharmaceutical Co. Ltd. Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient

Also Published As

Publication number Publication date
AU2438299A (en) 1999-08-23
EP1053255A4 (fr) 2003-01-02
KR20010024899A (ko) 2001-03-26
AP2000001876A0 (en) 2000-09-30
US20020107359A1 (en) 2002-08-08
EP1053255A1 (fr) 2000-11-22
NZ505914A (en) 2004-03-26
TR200002271T2 (tr) 2000-11-21
CA2316860A1 (fr) 1999-08-12
BR9907964A (pt) 2000-10-17
AU759378B2 (en) 2003-04-10
JP2004510681A (ja) 2004-04-08
NO20003964D0 (no) 2000-08-04
US6675105B2 (en) 2004-01-06
US20040054480A1 (en) 2004-03-18
CN1291198A (zh) 2001-04-11
WO1999040117A1 (fr) 1999-08-12
IL137583A0 (en) 2001-07-24
PL342297A1 (en) 2001-06-04
EA200000746A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
NO20003964L (no) Tredimensjonale strukturer og modeller av Fc reseptorer og anvendelser derav
DE69531681D1 (de) Spielbaustein-Set aus flexiblem Schaumstoff
ATE346515T1 (de) Simulierter rauchartikel und dafür vorgesehenes brennelement
DE60020795D1 (de) Echtzeitmodellierung des Verhaltens menschlicher Sehvermögenssysteme
DE60219242D1 (de) Dreidimensionales Rechnermodellierungsgerät
NO993338D0 (no) Fremstilling av mönstrede abrasive overflater
DE59910460D1 (de) Kombinationen aus herbiziden und safenern
DE59907567D1 (de) Kombinationen aus herbiziden und safenern
NO20005343D0 (no) Fastsettelse av formen og orienteringen til et borehull
NO20004752D0 (no) Flerlags plastrør og bruk av samme
NO20013665D0 (no) Kaliumsalt av (S)-omeprazol
NO20025758D0 (no) Anvendelse av skrueviklet rörkonstruksjon i brönnmiljöet
NO985549D0 (no) Akustisk bygge-element
DE19843632B8 (de) Gleichlaufgelenk
ID27835A (id) Piranti elektromagnit dan sirkuit untuk menggerakan piranti elektromagnit
DE69923833D1 (de) Hochporöse dreidimensionale Strukturen aus Chrom enthaltende Legierungen
DE69832634D1 (de) Gebondete flaum-strukturen und zugehöriges herstellungsverfahren
DE69833043D1 (de) Konsistenzerzwingung geologischer modelle
FR2827041B1 (fr) Dispositif piezoresistif et procedes de fabrication de ce dispositif
DE59500890D1 (de) Rohrschalen aus Schaumkunststoff
NO20014454D0 (no) Konstruksjon og anvendelse av samme
KR980000950U (ko) 다양한 형태의 블럭을 이용한 조립완구
KR970058499U (ko) 교량의 방호벽 신축 이음구
NO974966D0 (no) Nye anvendelser av heptafluorpropan
NO951495D0 (no) Bygningselement og anvendelse av samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application